Liquid Biopsy Market Global Trends, Share, Size, Analysis and Research Report 2024 to 2032

Comments ยท 3 Views

The global liquid biopsy market was valued at US$ 13.95 Billion in 2023, and is expected to register a CAGR of 7.6% over the forecast period and reach US$ 26.9 Bn in 2032.

The Reports and Insights, a leading market research company, has recently releases report titled “Liquid Biopsy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032.” The study provides a detailed analysis of the industry, including the global Liquid Biopsy Market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights:

How big is the Liquid Biopsy market?

The global liquid biopsy market was valued at US$ 13.95 Billion in 2023, and is expected to register a CAGR of 7.6% over the forecast period and reach US$ 26.9 Bn in 2032.

What is Liquid Biopsy?

Liquid biopsy is a minimally invasive diagnostic approach that involves examining a blood or other bodily fluid sample to detect and monitor diseases, notably cancer. Unlike conventional biopsies, which require invasive procedures to extract tissue samples, liquid biopsies analyze circulating tumor cells (CTCs), cell-free DNA (cfDNA), and other biomarkers to provide valuable insights into a patient's condition. This method is particularly beneficial for tracking treatment effectiveness, identifying disease relapse, and pinpointing genetic mutations that can inform personalized treatment plans.

Request for a sample copy with detail analysis: https://www.reportsandinsights.com/sample-request/2249

What are the growth prospects and trends in the Liquid Biopsy industry?

The liquid biopsy market growth is driven by various factors and trends. The liquid biopsy market is experiencing rapid growth, primarily due to the rising cancer rates and the need for less invasive diagnostic methods. This market includes various technologies, such as detecting circulating tumor cells (CTCs), analyzing cell-free DNA (cfDNA), and isolating exosomes, all of which allow for cancer and other diseases to be detected and monitored through simple blood tests. The market is characterized by extensive research and development efforts aimed at improving the accuracy, specificity, and cost-effectiveness of liquid biopsy tests. Major players in the market are focusing on forming strategic partnerships and collaborations to improve their product offerings and expand their presence in this expanding sector. Hence, all these factors contribute to liquid biopsy market growth.

What is included in market segmentation?

The report has segmented the market into the following categories:

By Sample Type

  • Blood-based Liquid Biopsy
  • Urine-based Liquid Biopsy
  • Saliva-based Liquid Biopsy
  • Cerebrospinal Fluid-based Liquid Biopsy

By Biomarker Type

  • Circulating Tumor DNA (ctDNA)
  • Circulating Tumor Cells (CTCs)
  • Extracellular Vesicles (EVs)
  • Other Biomarkers

By Application

  • Oncology
  • Infectious Disease Testing
  • Prenatal Testing
  • Transplant Rejection Monitoring

By End User

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies

By Region:

  • North America
  • Asia-Pacific
  • Europe
  • Latin America
  • Middle East
  • Africa

Who are the key players operating in the industry?

The report covers the major market players including: 

·       Thermo Fisher Scientific Inc.

·       Illumina, Inc.

·       BIOCEPT, INC.

·       Bio-Rad Laboratories, Inc.

·       Exact Science Corporation

·       Menarini Silicon Biosystems

·       Epic Sciences

·       NeoGenomics Laboratories

·       Mdxhealth

·       F. Hoffmann-La Roche Ltd.

·       QIAGEN

·       Oncocyte Corporation

·       Johnson & Johnson Services, Inc.

·       PathAI

·       Fluxion Biosciences Inc.

 

Buy Now : https://www.reportsandinsights.com/buy-now/2249

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

Rะตports and Insights consistะตntly mะตะตt intะตrnational bะตnchmarks in thะต markะตt rะตsะตarch industry and maintain a kะตะตn focus on providing only thะต highะตst quality of rะตports and analysis outlooks across markะตts, industriะตs, domains, sะตctors, and vะตrticals. Wะต havะต bะตะตn catะตring to varying markะตt nะตะตds and do not compromisะต on quality and rะตsะตarch ะตfforts in our objะตctivะต to dะตlivะตr only thะต vะตry bะตst to our cliะตnts globally.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact Us:

Reports and Insights Business Research Pvt. Ltd.
1820 Avenue M, Brooklyn, NY, 11230, United States
Contact No: +1-(347)-748-1518
Email:
[email protected]
Website: https://www.reportsandinsights.com/
Follow us on LinkedIn:
https://www.linkedin.com/company/report-and-insights/
Follow us on twitter:
https://twitter.com/ReportsandInsi1

 

 

 

 

 

Comments